The Value of Postoperative Radiation Therapy in Atypical Thymic Carcinoid Remains Unclear: A Population-Based Study

J. Wen,X. Xu,J. Chen,D. Liu,L. Xie,J. Zhang,M. Fan

DOI: https://doi.org/10.1016/j.ijrobp.2018.07.1806

2018-01-01

Abstract:Neuroendocrine tumors of the thymus (NETTs) were rare neoplasms, and were classified into 4 histological entities: typical and atypical carcinoids (ATCs), small-cell and large-cell neuroendocrine carcinomas. Studies have shown the biological behavior, survival and recurrence between these types were divergent, but the clinical features and optimal treatment modalities still remain controversial. We aim to evaluate the clinicopathological characteristics and survival outcomes of in ATCs patients, especially the value of postoperative radiotherapy and R0 resection. We used the SEER database [1973-2014] to identify patients who were diagnosed as ATCs. The clinic-pathologic data as well as the histologic features were recorded. Multivariate analyses by use of the Cox proportional hazards model were performed to evaluate the effect of covariate on OS. Kaplan-Meier survival curves were used to describe survival probability of OS. A total of 39 patients with primary ATCs were included. The median age was 57, the incidence was three times higher for men (29, 74.4%) than for women(10,25.6%). ATCs were more likely larger in size (mean 9.1 cm, SD=3.9). R0 resection was performed for 46.9% patients. 19 patients received postoperative radiotherapy. The mean survival (MS) time was 63.1 months. The 5-yr OS was 55.7%. OS was not significantly different between patients treated with postoperative radiotherapy (yes vs no, p=0.540), but significantly between patients treated with R0 resection (yes vs no, 5-yr OS: 80.8% vs 37.1%; p=0.012). For those received R0 resection, there were no significant differences in OS between patients undergone adjuvant radiotherapy (yes vs no, 5-yr OS:80.0% vs 57.10%; p=0.460). However, adjuvant radiotherapy showed a trend in increasing survival for patients who received R1/R2 resection (yes vs no, 5-yr OS: 75.0% vs 32.10%; p=0.152). Univariate Analysis showed female (HR=10.038, p=0.000), age older than sixty (HR=0.017, p=0.017), distant metastases (HR=1.470, p=0.024) and R1/R2 resection (HR=4.939, p=0.020) were independent risk factors for survival. Multivariable analysis showed female was associated with much higher risk of all-cause mortality (HR=5.711, p=0.025) compared with male. Patients with distant metastases had worse OS than non-metastases patients (HR=1.879, p=0.030), postoperative radiotherapy wasn’t associated with longer OS (HR=1.579, p=0.484). To our knowledge, this is the first report investigating the epidemiological factors and survival trends in ATCs based the SEER database. We suggest that ATCs primarily afflict males, usually in the fifth decade of life. R0 surgical resection is recommended for ATCs. Patients might benefit from R1/R2 resection plus adjuvant radiotherapy, and have an OS approximate to those who accept R0 resection alone. However, the role of postoperative radiotherapy for ATCs warrant prospective evaluation in clinical trials.